4011 - 4020 of 8819 Results
Title
Year
-
OPENTitle: Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriersJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 24Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000010863Best OA location URL: https://n.neurology.org/content/neurology/95/24/e3428.full.pdfCitation Count: 51
- A protease protection assay for the detection of internalized alpha-synuclein pre-formed fibrils2021OPENTitle: A protease protection assay for the detection of internalized alpha-synuclein pre-formed fibrilsJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 1Start Page: e0241161End Page: e0241161Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0241161Best OA location URL: https://doi.org/10.1371/journal.pone.0241161Citation Count: 6
-
OPENTitle: Early-Onset Parkinson Disease Screening in Patients From NigeriaJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.594927Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.594927/pdfCitation Count: 7
-
OPENTitle: Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-020-01117-yBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-020-01117-yCitation Count: 30
-
OPENTitle: Real-world assessment of the impact of “OFF” episodes on health-related quality of life among patients with Parkinson’s disease in the United StatesJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-021-02074-2Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-021-02074-2Citation Count: 18
-
OPENTitle: Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanismsJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 478Issue #: 3Start Page: 553End Page: 578Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20200937Best OA location URL: https://portlandpress.com/biochemj/article-pdf/478/3/553/904049/bcj-2020-0937.pdfCitation Count: 44
-
OPENTitle: Effects of Excess Brain-Derived Human α-Synuclein on Synaptic Vesicle TraffickingJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.639414Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.639414/pdfCitation Count: 15
-
OPENTitle: PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic dataJournal Name: MicrobiomePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40168-020-00993-9Best OA location URL: https://microbiomejournal.biomedcentral.com/track/pdf/10.1186/s40168-020-00993-9Citation Count: 145
- APOE and MAPT Are Associated With Dementia in Neuropathologically Confirmed Parkinson's Disease2021OPENTitle: APOE and MAPT Are Associated With Dementia in Neuropathologically Confirmed Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.631145Best OA location URL: https://doi.org/10.3389/fneur.2021.631145Citation Count: 41
-
OPENTitle: The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier statusJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-021-00778-8Best OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-021-00778-8Citation Count: 54